Adenosine triphosphate (or ATP) is the main source of energy in the human body. Macroergic bonds contribute to the formation of energy during the destruction of ATP. Intramuscularly incoming energy is spent both on maintaining a constant temperature of the body and its organs, and on the contraction of muscle fibers. All biochemical processes in the human body that occur with the release of energy, one way or another, are associated with the action of ATP.
In addition to its main (energy) function, adenosine triphosphate serves as a source for the synthesis of various nucleic acids, performs the regulatory function of most enzymatic processes (by integrating into the center of the enzymatic system and controlling its activity) and is involved in the transmission of nerve impulses. In addition, adenosine triphosphate is the precursor (source of synthesis) of monophosphate, which promotes the transmission of hormonal signals to cells and tissues of the human body.
The great importance of ATP for the normal functioning of the human body necessitated the creation of a drug based on it. This drug exists in various forms of release (in the form of powder, tablets and injections). The most common injection of ATP. The receipt of the active substance in the tissue in this case occurs almost instantly. As a result, the effect of the drug is accelerated and the effectiveness of ATP is increased. The instruction says that it is necessary to prescribe a drug for the treatment of various kinds of dystrophy, atrophy and the usual spastic condition of peripheral vessels. In addition, the drug is successfully used by athletes for quick recovery after exhausting workouts, as well as to increase endurance and performance. This tool is almost indispensable during the period of pre-competitive training of athletes.
ATP is intramuscularly used to restore normal heart function, improve brain blood supply and reduce the risk of myocardial infarction.
The use of tablet forms of the drug (mainly for sublingual use) is carried out in preventive cases.
If the patient has vegetative-vascular dystonia, arrhythmia or cardiosclerosis, ATP is administered intramuscularly.
The use of the drug for more than a month is not recommended. In this case, you need to take a break for two to three weeks, and then continue taking the pharmaceutical drug.
In the case when ATP is not administered intramuscularly, it is taken parenterally, there is a risk of side effects. First of all, taking adenosine triphosphate causes discomfort in the esophagus and stomach, nausea and even vomiting. Exceeding the maximum daily dose (about 600 milligrams for an adult and about 250 for a child) of the drug can lead to the development of allergic reactions, as well as an excess of potassium and magnesium (which is fraught with disorders in the cardiovascular system).
Contraindications for the use of the drug:
- diagnosed myocardial infarction
- the presence of a stroke
- bronchial asthma
- pregnancy and lactation
- hypersensitivity to the components of the drug
Refuse the use of ATP is necessary for patients who use potassium and magnesium preparations and other drugs that cause stimulation of cardiac activity.
Summing up, I want to say that ATP plays a significant role in the human body, being the central link in all its energy processes, and its use as a medicine is often not only justified, but also necessary.